Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S9 (MRPS9) is a protein encoded by the nuclear MRPS9 gene and is a structural component of the small 28S subunit of the mitochondrial ribosome (mitoribosome) in mammals. These ribosomal proteins facilitate protein synthesis within mitochondria. Unlike cytoplasmic ribosomes, mitochondrial ribosomes have a higher protein-to-rRNA ratio and differ notably in their biochemical composition and sequence across species. MRPS9 is necessary for mitochondrial translation, but is not recognized as a druggable target or disease-associated protein in most current research.
None known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S9 (MRPS9).